Whooping cough vaccination during pregnancy boosts newborn immunity
Researchers have shown for the first time that maternal antibodies are found not only in the blood of newborns, but also in the nasal mucosa. The international study,… read more.
Researchers have shown for the first time that maternal antibodies are found not only in the blood of newborns, but also in the nasal mucosa. The international study,… read more.
Prompt, individual-based dose assessment is essential to protect people from the negative consequences of radiation exposure after large-scale nuclear or radiological incidents. However, traditional dosimetry methods often require… read more.
A new, fast and easy test could revolutionize blood transfusions—giving blood centers and hospitals a reliable way to monitor the quality of red blood cells after they sit… read more.
Subtle abnormalities in kidney function – even within the range considered normal – may help identify people at risk of developing chronic kidney disease. This is shown in… read more.
Telix Pharmaceuticals Limited announces that the Chinese National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) has accepted the filing of a New Drug Application (NDA) for… read more.
In a proof-of-concept study funded by the National Institutes of Health, researchers from the Keck School of Medicine of USC and the California Institute of Technology (Caltech) have shown that… read more.
There has been a lasting and disproportionate impact of the Covid-19 pandemic on diagnosis rates for conditions including depression, asthma and osteoporosis. Depression is the most severely impacted,… read more.
Camurus announced that the FDA has accepted for review the company’s resubmission of the New Drug Application (NDA) for Oclaiz (CAM 2029), octreotide extended-release injection, for the treatment… read more.
Arrowhead Pharmaceuticals, Inc. announced that the Chinese National Medical Products Administration (NMPA) has approved Redemplo (plozasiran) for the reduction of triglyceride levels in adult patients with familial chylomicronemia… read more.
Caris Life Sciences announced that its therapeutic research arm, Caris Discovery, has entered into a multi-year collaboration and license agreement with Genentech, a member of the Roche Group. In… read more.
Abeona Therapeutics Inc. announced the first patient treatment with FDA-approved Zevaskyn (prademagene zamikeracel), a first-of-its-kind, autologous gene therapy for treating wounds in adult and pediatric patients with recessive… read more.
A test using genetics to predict who is at the highest risk of developing type 1 diabetes could one day be applied to largescale health studies, to identify… read more.